Johnson & Johnson SEC filings JNJ

Johnson & Johnson has 1,000 filings in SEC EDGAR's recent list, going back to Aug 2, 2018. Its latest annual report, Form ARS, was filed on Mar 11, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on January 3.

Form Description Filed Period
ARS Annual report to shareholders Mar 11, 2026 Dec 28, 2025
10-K Annual report Feb 11, 2026 Dec 28, 2025
ARS Annual report to shareholders Mar 12, 2025 Dec 29, 2024
10-K Annual report Feb 13, 2025 Dec 29, 2024
ARS Annual report to shareholders Mar 13, 2024 Dec 31, 2023
10-K Annual report Feb 16, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 16, 2023 Jan 1, 2023
10-K Annual report Feb 16, 2023 Jan 1, 2023
10-K Annual report Feb 17, 2022 Jan 2, 2022
10-K Annual report Feb 22, 2021 Jan 3, 2021
10-K Annual report Feb 18, 2020 Dec 29, 2019
10-K Annual report Feb 20, 2019 Dec 30, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
JNJ (NYSE)
Fiscal year ends
January 3
Incorporated in
NJ
Headquarters
New Brunswick, NJ
SEC filer status
Large accelerated filer
SEC CIK
200406
Former names
JOHNSON & JOHNSON ET AL (until Jan 23, 1996)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.